Table 3.
Abstinence rates by community use level and pairwise ATEs and ATTs before and after propensity score weighting.
| None
|
Passive
|
Both
|
Difference*
|
||
|---|---|---|---|---|---|
| Rate (95% CI) | Rate (95% CI) | Rate (95% CI) | ΔRate (95% CI) | p-value | |
|
|
|
|
|
|
|
| Unweighted Analyses | .124 (.070, .178) | .244 (.151, .337) | .355 (.283, .426) | ||
| Passive vs. None | -- | -- | -- | .120 (.012, .227) | .028 |
| Both vs. None | -- | -- | -- | .231 (.141, .320) | <.001 |
| Both vs. Passive | -- | -- | -- | .111 (-.007, .228) | .064 |
|
|
|
|
|
|
|
| ATE Weighted Analyses | .122 (.067, .177) | .252 (.151, .352) | .355 (.281, .429) | ||
| Passive vs. None | -- | -- | -- | .130 (.015, .244) | .026 |
| Both vs. None | -- | -- | -- | .233 (.141, .325) | <.001 |
| Both vs. Passive | -- | -- | -- | .103 (-.022, .228) | .105 |
|
|
|
|
|
|
|
| ATT weighted to match "None" | .124 (.070, .178) | .279 (.159, .399) | .350 (.266, .433) | ||
| Passive vs. None | -- | -- | -- | .155 (.023, .287) | .021 |
| Both vs. None | -- | -- | -- | .226 (.126, .325) | <.001 |
|
|
|
|
|
|
|
| ATT weighted to match "Passive" | .121 (.058, .184) | .244 (.151, .337) | .327 (.231, .423) | ||
| None vs. Passive | -- | -- | -- | −.123 (−.235, −.010) | .032 |
| Both vs. Passive | -- | -- | -- | .083 (.050, .217) | .221 |
|
|
|
|
|
|
|
| ATT weighted to match "Both" | .143 (.064, .223) | .230 (.125, .335) | .355 (.283, .426) | ||
| None vs. Both | -- | -- | -- | −.211 (−.318, −.105) | <.001 |
| Passive vs. Both | -- | -- | -- | −.124 (−.252, .003) | .055 |
|
|
|
|
|
|
|
*
Differences are calculated as 1st group – 2nd group, where pairs are expressed as "1st group vs. 2nd group".
Notes: ATE weighted estimates represent estimated abstinence rates if the whole population received the corresponding treatments. ATT weighted estimates represent estimated abstinence rates if the matched population received corresponding treatments.